Blau Farmacêutica S.A. (BVMF: BLAU3)

Blau Farmacêutica Statistics

Total Valuation

Blau Farmacêutica has a market cap or net worth of BRL 2.50 billion. The enterprise value is 2.60 billion.

Market Cap	2.50B
Enterprise Value	2.60B

Important Dates

The next estimated earnings date is Wednesday, March 19, 2025.

Earnings Date	Mar 19, 2025
Ex-Dividend Date	Sep 27, 2024

Share Statistics

Blau Farmacêutica has 177.68 million shares outstanding. The number of shares has decreased by -0.08% in one year.

Current Share Class	n/a
Shares Outstanding	177.68M
Shares Change (YoY)	-0.08%
Shares Change (QoQ)	+156.12%
Owned by Insiders (%)	83.30%
Owned by Institutions (%)	5.85%
Float	29.68M

Valuation Ratios

The trailing PE ratio is 13.35 and the forward PE ratio is 8.69. Blau Farmacêutica's PEG ratio is 0.48.

PE Ratio	13.35
Forward PE	8.69
PS Ratio	1.48
PB Ratio	1.19
P/TBV Ratio	1.32
P/FCF Ratio	11.66
P/OCF Ratio	n/a
PEG Ratio	0.48

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.44, with an EV/FCF ratio of 12.15.

EV / Earnings	13.91
EV / Sales	1.54
EV / EBITDA	8.44
EV / EBIT	9.78
EV / FCF	12.15

Financial Position

The company has a current ratio of 3.48, with a Debt / Equity ratio of 0.26.

Current Ratio	3.48
Quick Ratio	2.27
Debt / Equity	0.26
Debt / EBITDA	1.78
Debt / FCF	2.57
Interest Coverage	4.13

Financial Efficiency

Return on equity (ROE) is 9.05% and return on invested capital (ROIC) is 6.38%.

Return on Equity (ROE)	9.05%
Return on Assets (ROA)	5.26%
Return on Capital (ROIC)	6.38%
Revenue Per Employee	887,276
Profits Per Employee	98,445
Employee Count	1,900
Asset Turnover	0.53
Inventory Turnover	1.82

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.62% in the last 52 weeks. The beta is 0.40, so Blau Farmacêutica's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-12.62%
50-Day Moving Average	14.39
200-Day Moving Average	12.22
Relative Strength Index (RSI)	50.72
Average Volume (20 Days)	309,670

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Blau Farmacêutica had revenue of BRL 1.69 billion and earned 187.05 million in profits. Earnings per share was 1.05.

Revenue	1.69B
Gross Profit	596.47M
Operating Income	265.88M
Pretax Income	238.24M
Net Income	187.05M
EBITDA	302.15M
EBIT	265.88M
Earnings Per Share (EPS)	1.05

Balance Sheet

The company has 431.95 million in cash and 549.51 million in debt, giving a net cash position of -117.57 million or -0.66 per share.

Cash & Cash Equivalents	431.95M
Total Debt	549.51M
Net Cash	-117.57M
Net Cash Per Share	-0.66
Equity (Book Value)	2.08B
Book Value Per Share	11.80
Working Capital	1.13B

Cash Flow

In the last 12 months, operating cash flow was 332.65 million and capital expenditures -118.48 million, giving a free cash flow of 214.17 million.

Operating Cash Flow	332.65M
Capital Expenditures	-118.48M
Free Cash Flow	214.17M
FCF Per Share	1.21

Margins

Gross margin is 35.38%, with operating and profit margins of 15.77% and 11.10%.

Gross Margin	35.38%
Operating Margin	15.77%
Pretax Margin	14.13%
Profit Margin	11.10%
EBITDA Margin	17.92%
EBIT Margin	15.77%
FCF Margin	12.70%

Dividends & Yields

This stock pays an annual dividend of 0.75, which amounts to a dividend yield of 5.32%.

Dividend Per Share	0.75
Dividend Yield	5.32%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	36.38%
Buyback Yield	0.08%
Shareholder Yield	5.40%
Earnings Yield	7.49%
FCF Yield	8.58%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Blau Farmacêutica has an Altman Z-Score of 2.77. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.77
Piotroski F-Score	n/a